Cutler Group LP Regenxbio Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Regenxbio Inc. stock. As of the latest transaction made, Cutler Group LP holds 2,100 shares of RGNX stock, worth $15,267. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,100

Previous 1,300 61.54%

Holding current value

$15,267

Previous $4,000 50.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	SELL	$17.23 - $21.71 $40,714 - $51,300	-2,363 Reduced 66.32%	1,200 $23,000
Q1 2023 May 01, 2023	BUY	$18.08 - $24.55 $48,942 - $66,456	2,707 Added 316.24%	3,563 $67,000
Q4 2022 Feb 07, 2023	BUY	$20.4 - $24.73 $12,974 - $15,728	636 Added 289.09%	856 $19,000
Q3 2022 Oct 25, 2022	SELL	$22.29 - $35.04 $8,470 - $13,315	-380 Reduced 63.33%	220 $5,000
Q2 2022 Aug 04, 2022	BUY	$19.35 - $35.04 $11,610 - $21,024	600 New	600 $14,000
Q4 2021 Jan 18, 2022	SELL	$30.19 - $40.28 $36,228 - $48,336	-1,200 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$29.09 - $45.68 $6,457 - $10,140	-222 Reduced 15.61%	1,200 $50,000
Q2 2021 Jul 19, 2021	BUY	$32.46 - $40.48 $39,666 - $49,466	1,222 Added 611.0%	1,422 $55,000
Q1 2021 Apr 26, 2021	SELL	$33.61 - $49.95 $107,552 - $159,840	-3,200 Reduced 94.12%	200 $6,000
Q4 2020 Jan 21, 2021	BUY	$26.52 - $49.35 $42,432 - $78,960	1,600 Added 88.89%	3,400 $154,000
Q1 2020 May 07, 2020	BUY	$21.5 - $54.2 $12,900 - $32,520	600 Added 50.0%	1,800 $58,000
Q4 2019 Feb 06, 2020	BUY	$34.54 - $44.87 $10,362 - $13,461	300 Added 33.33%	1,200 $49,000
Q3 2019 Oct 28, 2019	SELL	$31.84 - $50.88 $203,776 - $325,632	-6,400 Reduced 87.67%	900 $32,000
Q2 2019 Aug 09, 2019	BUY	$42.0 - $59.29 $184,800 - $260,876	4,400 Added 151.72%	7,300 $375,000
Q1 2019 May 10, 2019	SELL	$40.82 - $62.45 $53,066 - $81,185	-1,300 Reduced 30.95%	2,900 $166,000
Q4 2018 Feb 05, 2019	SELL	$39.11 - $75.15 $54,754 - $105,210	-1,400 Reduced 25.0%	4,200 $176,000
Q3 2018 Nov 07, 2018	BUY	$65.0 - $82.15 $340,145 - $429,890	5,233 Added 1425.89%	5,600 $422,000
Q2 2018 Aug 10, 2018	SELL	$27.2 - $74.35 $14,497 - $39,628	-533 Reduced 59.22%	367 $26,000
Q1 2018 May 11, 2018	SELL	$24.05 - $37.5 $176,935 - $275,887	-7,357 Reduced 89.1%	900 $26,000
Q4 2017 Jan 17, 2018	BUY	$26.0 - $34.6 $117,104 - $155,838	4,504 Added 120.01%	8,257 $274,000
Q3 2017 Oct 17, 2017	BUY	$18.0 - $32.95 $67,554 - $123,661	3,753	3,753 $123,000

Others Institutions Holding RGNX

# of Institutions

191

Shares Held

45.4M

Call Options Held

184K

Put Options Held

56.7K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $314M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account